InhibrxInc Pretax Profit Margin from 2010 to 2024
| INBX Stock | USD 34.74 0.24 0.69% |
Pretax Profit Margin | First Reported 2010-12-31 | Previous Quarter (133.18) | Current Value (126.52) | Quarterly Volatility 45.56757487 |
Check InhibrxInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InhibrxInc main balance sheet or income statement drivers, such as Interest Expense of 33.4 M, Minority Interest of 0.0 or Tax Provision of 2.6 K, as well as many exotic indicators such as Price To Sales Ratio of 1 K, Dividend Yield of 0.0021 or PTB Ratio of 43.23. InhibrxInc financial statements analysis is a perfect complement when working with InhibrxInc Valuation or Volatility modules.
InhibrxInc | Pretax Profit Margin |
Latest InhibrxInc's Pretax Profit Margin Growth Pattern
Below is the plot of the Pretax Profit Margin of InhibrxInc over the last few years. It is InhibrxInc's Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in InhibrxInc's overall financial position and show how it may be relating to other accounts over time.
| Pretax Profit Margin | 10 Years Trend |
|
Pretax Profit Margin |
| Timeline |
InhibrxInc Pretax Profit Margin Regression Statistics
| Arithmetic Mean | (25.03) | |
| Coefficient Of Variation | (182.07) | |
| Mean Deviation | 33.51 | |
| Median | (2.75) | |
| Standard Deviation | 45.57 | |
| Sample Variance | 2,076 | |
| Range | 130 | |
| R-Value | (0.71) | |
| Mean Square Error | 1,115 | |
| R-Squared | 0.50 | |
| Significance | 0 | |
| Slope | (7.21) | |
| Total Sum of Squares | 29,070 |
InhibrxInc Pretax Profit Margin History
About InhibrxInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include InhibrxInc income statement, its balance sheet, and the statement of cash flows. InhibrxInc investors use historical funamental indicators, such as InhibrxInc's Pretax Profit Margin, to determine how well the company is positioned to perform in the future. Although InhibrxInc investors may use each financial statement separately, they are all related. The changes in InhibrxInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on InhibrxInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on InhibrxInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in InhibrxInc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (133.18) | (126.52) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards InhibrxInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, InhibrxInc's short interest history, or implied volatility extrapolated from InhibrxInc options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of InhibrxInc Correlation against competitors. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for InhibrxInc Stock analysis
When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.12) | Revenue Per Share 0.038 | Quarterly Revenue Growth 4.964 | Return On Assets (0.46) | Return On Equity (4.75) |
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.